Clinical Trial Update: A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicating COM503 is being studied in participants with advanced solid tumors, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• COM503

Snippet

Sponsor: Compugen Ltd | Conditions: Neoplasm, Cancer, Malignant Tumors | Phase 1 | Status: RECRUITING